Onconova Logo BLUE.jpg
Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series
January 26, 2023 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Logo BLUE.jpg
Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference
December 07, 2022 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...
Onconova Logo BLUE.jpg
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
November 14, 2022 16:05 ET | Onconova Therapeutics, Inc.
Initiation of Phase 1/2a endometrial cancer trial expected in 1Q23; preliminary data expected 4Q23 Conference call and live webcast at 4:30 p.m. ET today NEWTOWN, Pa., Nov. 14, 2022 (GLOBE...
Onconova Logo BLUE.jpg
Onconova Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022 08:00 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Onconova Logo BLUE.jpg
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022 16:05 ET | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...